Curium News and Resources

Curium, a global company in nuclear medicine, has completed the acquisition of Nucleis, a GMP manufacturer and distributor of PET radiopharmaceutical drugs based in Belgium. The transaction supports Curium’s strategy to strengthen its position in the PET imaging market and